image
unknown
table
stringlengths
34
20.2k
sample_id
int64
0
153k
null
|Characteristic | Value | |---|---| | Bayes A | 0.71 | | Bayes B 0.95 | 0.92 | | Bayes B 0.996 | 0.89 | | Bayes C 0 | 0.7 | | Bayes C 0.95 | 0.88 | | Bayes C 0.996 | 0.9 | | Bayes Cn 0.95 | 0.9 | | Bayes Cn 0.996 | 0.9|
200
null
|Characteristic | Low-white | Mixed | High-white | |---|---|---|---| | Low Income | 3.52 | 4.0 | 4.4 | | Mid Income | 3.84 | 4.08 | 4.29 | | High Income | 4.35 | 4.13 | 3.91|
201
null
|Characteristic | 50 K Bayes C0 | 50 K Bayes B0.95 | 700K Bayes C0 | 700 K Bayes B0.9997 | |---|---|---|---|---| | +/-1 SNP | 0.55 | 0.46 | 0.81 | 0.46 | | +/-2 SNP | 0.64 | 0.57 | 0.82 | 0.57 | | +/-5 SNP | 0.68 | 0.73 | 0.82 | 0.75 | | +/-10 SNP | 0.74 | 0.82 | 0.8 | 0.84 | | +/- 50 SNP | 0.79 | 0.9 | 0.77 | 0.96 | | +/- 100 SNP | 0.79 | 0.92 | 0.79 | 0.98 | | All SNPs | 0.7 | 0.92 | 0.71 | 0.99|
202
null
|Characteristic | Value | |---|---| | Group I | 0.01 | | Group II | 0.0 | | Group III | 0.0 | | Group IV | 0.01 | | Group V | 0.01 | | Group VI | 0.01|
203
null
|Characteristic | Value | |---|---| | miR-22 | 1.49 | | miR-122 | 2.17 | | miR-320a | 4.16|
204
null
|Characteristic | No FS | FS | |---|---|---| | 1:10 | 9.66 | 10.05 | | 1:50 | 22.26 | 56.99 | | 1:100 | 35.62 | 73.41 | | 1:150 | 35.62 | 73.41 | | 1:200 | 35.62 | 86.77|
205
null
|Characteristic | Sulphoric acid attack | Hydrochloric acid attackHydrochloric acid attack | |---|---|---| | Control | 3.28 | 2.29 | | T5 | 5.05 | 3.25 | | T10 | 6.17 | 4.27 | | T15 | 6.77 | 4.57 | | T5Z10 | 5.27 | 3.28 | | T5Z15 | 5.78 | 3.49 | | T10Z10 | 6.26 | 3.88 | | T10Z15 | 6.86 | 4.18 | | T15Z10 | 6.95 | 4.57 | | T15Z15 | 7.46 | 4.75|
206
null
|Characteristic | (G) | (P) | |---|---|---| | G1 | -0.02 | -0.01 | | G2 | 0.09 | 0.66 | | G3 | 0.15 | 0.18 | | G4 | 0.14 | 0.17 | | G5 | 0.21 | 0.21 | | G6 | 0.27 | 0.16 | | G7 | 0.34 | 0.21 | | G8 | 0.47 | 0.34 | | G9 | 0.46 | -0.39 | | G10 | 0.78 | 0.34 | | G11 | 1.44 | 1.57 | | G12 | 1.59 | 1.32|
207
null
|Characteristic | Value | |---|---| | Jan | 44515.83 | | Feb | 42690.88 | | Mar | 60484.17 | | April | 67783.99 | | May | 65730.91 | | June | 66415.27 | | July | 68240.22 | | Aug | 64818.44 | | Sept | 52956.24 | | Oct | 50675.05 | | Nov | 56834.26 | | Dec | 51815.64|
208
null
|Characteristic | Value | |---|---| | 0.0 | 2.61 | | 0.02 | 688.33 | | 0.25 | 899.19|
209
null
|Characteristic | Energy | Price | |---|---|---| | Cement 1 | 0.04 | 0.01 | | Cement 2 | 0.05 | 0.01 | | Cement 3 | 0.02 | 0.01 | | Cement 4 | 0.02 | 0.03|
210
null
|Characteristic | Value | |---|---| | -201.06 | 2756.2 | | -64.49 | 7767.48 | | -61.08 | 42846.4 | | -58.35 | 75419.69 | | -54.25 | 396141.32 | | -51.52 | 441242.8 | | -42.64 | 75419.69 | | -39.91 | 32823.85 | | -36.5 | 5261.84 | | 199.08 | 5261.84|
211
null
|Characteristic | Value | |---|---| | 200.0 | 43.9 | | 300.0 | 91.24 | | 400.0 | 123.79 | | 500.0 | 125.76 | | 600.0 | 248.06|
212
null
|Characteristic | Value | |---|---| | High total sitting time/insutficient PA | 67.5 | | High total sitting time/sufficient PA | 74.73 | | Low total sitting time/sufficient PA | 80.04|
213
null
|Characteristic | Value | |---|---| | No breastfeeding problems | 82.94 | | Difficulties getting milkproduction started | 47.57 | | The child had difficulties suckling | 54.15 | | Sore nipples | 56.19 | | Insufficient breastmilk | 31.49 | | Other | 56.34|
214
null
|Characteristic | Value | |---|---| | DPP4 | 798.82 | | Con | 97.44 | | DPP4i 25 | 39.75 | | HCD | 58.98 | | MSN-HCD | 282.41|
215
null
|Characteristic | Value | |---|---| | 0.0 | 38.96 | | 1.0 | 28.25 | | 2.0 | 20.05 | | 3.0 | 11.29 | | 4.0 | 12.13 | | 5.0 | 7.33|
216
null
|Characteristic | men | women | |---|---|---| | without MI | 0.71 | 0.5 | | with MI | 2.14 | 7.71 | | Without DM | 0.36 | 0.67 | | with DM | 3.44 | 0.61|
217
null
|Characteristic | bare | TEOS | APTMS | TEOS/APTMS | |---|---|---|---|---| | 0.0 | 100.56 | 100.56 | 100.56 | 100.56 | | 200.0 | 94.78 | 95.93 | 93.82 | 97.38 | | 400.0 | 92.47 | 91.51 | 91.31 | 94.78 | | 600.0 | 90.74 | 91.89 | 88.62 | 92.47 | | 800.0 | 90.35 | 88.62 | 86.69 | 89.0 | | 1000.0 | 88.71 | 89.58 | 84.67 | 89.0|
218
null
|Characteristic | Value | |---|---| | 0.0 | 20.2 | | DBP(1.00) | 62.92 | | DEHP (1.50) | 40.28 | | DIDP(1.50) | 18.49 | | DINP (1.50) | 36.43 | | DNOP(1.50) | 23.19|
219
null
|Characteristic | Carbide | Al203/TiAlN | Diamond | |---|---|---|---| | Dry | 11.25 | 13.0 | 10.15 | | MQL | 17.54 | 24.55 | 14.7|
220
null
|Characteristic | Value | |---|---| | Underweight | 0.92 | | Normal weight | 7.03 | | Overweight | 31.8 | | Obesity Class | |I | 32.11 | | Obesity Class | |II | 19.27 | | Obesity Class| |III | 8.87|
221
null
|Characteristic | Carbide | Al_{2}0_{3}/TiAIN | Diamond | |---|---|---|---| | ST1-Dry | 276.47 | 252.02 | 314.68 | | ST2-Dry | 298.68 | 268.02 | 338.68 | | ST3-Dry | 334.68 | 344.01 | 368.01 | | STI-MQL | 268.47 | 234.69 | 294.68 | | ST2-MQL | 270.24 | 244.03 | 304.02 | | ST3-MQL | 282.69 | 257.36 | 326.68 | | AVE-Dry | 300.46 | 288.02 | 348.01 | | AVE-MQL | 275.58 | 248.03 | 306.68|
222
null
|Characteristic | CGCM3 | Miroc-Med | MRI_CGCM2 | CNRM | ECHAMS | ECHO-G | GFDL2.0 | GFDL2.1 | Maurer | |---|---|---|---|---|---|---|---|---|---| | 0-3 | 0.0 | 0.33 | 0.07 | 1.0 | 0.1 | 1.0 | 1.0 | 0.73 | 0.0 | | 4-7 | 0.1 | 0.2 | 0.07 | 0.0 | 0.24 | 0.0 | 0.0 | 0.13 | 0.0 | | 8-11 | 0.13 | 0.3 | 0.4 | 0.0 | 0.27 | 0.0 | 0.0 | 0.07 | 0.1 | | 12-15 | 0.44 | 0.1 | 0.13 | 0.0 | 0.24 | 0.0 | 0.0 | 0.0 | 0.21 | | 16-19 | 0.27 | 0.0 | 0.3 | 0.0 | 0.13 | 0.0 | 0.0 | 0.03 | 0.24 | | 20-23 | 0.03 | 0.07 | 0.03 | 0.0 | 0.03 | 0.0 | 0.0 | 0.04 | 0.24 | | 24-27 | 0.03 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.21 | | 28-31 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0|
223
null
|Characteristic | Value | |---|---| | BMI | 31.57 | | Chol | 18.8 | | SBP | 12.71 | | DBP | 12.41 | | F| |V | 89.66 | | PA | 99.7|
224
null
|Characteristic | 65 + | 45~64 | 19~44 | 7 ~18 | |---|---|---|---|---| | suffocation | -3.19 | 4.45 | 6.55 | -6.15 | | drowning | -0.13 | 1.64 | 0.52 | -0.13 | | fire | -0.13 | 0.13 | -0.59 | -0.33 | | fall | 0.59 | 3.8 | 5.56 | 27.89 | | poisoning | 2.23 | -10.15 | -12.44 | -21.41 | | transport | -0.07 | -0.13 | -0.13 | -0.13|
225
null
|Characteristic | 1 time | 2 to 3 times | 5 or above | |---|---|---|---| | 2004.0 | 85.0 | 14.0 | 2.0 | | 2005.0 | 77.0 | 16.0 | 7.0 | | 2006.0 | 49.0 | 26.0 | 25.0 | | 2007.0 | 38.0 | 28.0 | 34.0 | | 2008.0 | 32.0 | 28.0 | 39.0|
226
null
|Characteristic | Value | |---|---| | Overall | -0.02 | | Bar | 0.06 | | Restaurant | -0.08 | | Overall | 0.1 | | Bar | 0.15 | | Restaurant | 0.08|
227
null
|Characteristic | Value | |---|---| | PLAND_Sea | 33.5 | | CONTIG_MN_Food_services | 16.8 | | PROX_MN_Food_services | 9.47 | | SHAFE_MN_Sea | 3.95 | | CP_Building 100 | 3.05 | | LAeq | -17.48|
228
null
|Characteristic | Value | |---|---| | 2009.0 | 0.92 | | 2010.0 | 4.59 | | 2011.0 | 3.82 | | 2012.0 | 3.14 | | 2013.0 | 1.72|
229
null
|Characteristic | no iron supplement | iron supplement | |---|---|---| | S. aureus SA | -22.51 | -19.94 | | Staphylococcus sp. SH | -34.38 | -25.08 | | R. erythropolis (ethanol) | -39.52 | -34.77 | | R. erythropolis (hexadecane) | 4.38 | 4.58|
230
null
|Characteristic | Value | |---|---| | Territories | 0.3 | | British Columbia | 0.16 | | Alberta | 0.14 | | Saskatchewan | 0.16 | | Manitoba | 0.2 | | Ontario | 0.18 | | Quebec | 0.17 | | New Brunswick | 0.16 | | NovaScotia | 0.15 | | Prince Edward Island | 0.11 | | Newfoundland | 0.16|
231
null
|Characteristic | Male | Female | All cases | |---|---|---|---| | 0-4 | 16247.63 | 5915.27 | 11339.76 | | 5-14 | 15343.55 | 26709.14 | 20509.73 | | 15-29 | 11468.92 | 20251.42 | 15731.01 | | 30-64 | 9660.75 | 17410.02 | 13406.23 | | ?65 | 8369.21 | 6561.05 | 7206.82|
232
null
|Characteristic | Value | |---|---| | P-20-ExRP | 100.14 | | P-15-ExRP | 100.14 | | P-10-ExRP | 100.14 | | P-5-ExRP | 100.14 | | P-20-ExOP1230 | 78.35 | | P-15-ExOP1230 | 78.77 | | P-10-ExOP1230 | 86.31 | | P-5-ExOP1230 | 97.63 | | P-20-ExOP935 | 89.25 | | P-15-ExOP935 | 84.22 | | P-10-ExOP935 | 101.82 | | P-5-ExOP935 | 100.14 | | P | 0.08|
233
null
|Characteristic | AC | HS | |---|---|---| | 2.0 | 2.27 | 3.36 | | 4.0 | 4.05 | 6.52 | | 6.0 | 7.98 | 12.41|
234
null
|Characteristic | Value | |---|---| | 20-29 | 18.06 | | 30-39 | 18.06 | | 40-49 | 29.05 | | 50-59 | 13.08 | | 60.0 | 2.08|
235
null
|Characteristic | Male | Female | |---|---|---| | Kusaurara | 22.84 | 13.89 | | Dunniya J'atau | 21.16 | 14.73 | | A New Dawn | 8.59 | 7.19 | | One thing At A Time | 7.19 | 4.67 | | Gari Muna Fati | 22.0 | 13.34 | | Abule Olokemerin | 18.37 | 16.97 | | Odenjinjin | 15.57 | 18.09 | | TV Femi Kuti | 21.44 | 12.78 | | TV Fati Mohammed | 15.57 | 10.54 | | Printed Ads | 54.6 | 41.84 | | Visited Clinic | 23.4 | 27.03 | | Viited by FP worker | 24.79 | 22.56|
236
null
|Characteristic | Controls | Cases | |---|---|---| | 1.0 | 3.4 | 2.2 | | 2.0 | 0.7 | 0.9 | | 3.0 | 8.0 | 5.0 | | 4.0 | 4.5 | 3.4 | | 5.0 | 2.8 | 3.7 | | 6.0 | 2.8 | 3.8 | | 7.0 | 25.2 | 35.5 | | 8.0 | 14.3 | 28.4 | | 9.0 | 1.7 | 4.3 | | 0.0 | 0.6 | 0.9|
237
null
|Characteristic | 2 min - 5 min per day | > 5 min - 15 min per day | <2 min per day | >60 min per day | > 15 min - 30 min per day | > 30 min - 60 min per day | |---|---|---|---|---|---|---| | 7.0 | 0.07 | 0.0 | 0.92 | 0.0 | 0.01 | 0.0 | | 8.0 | 0.08 | 0.02 | 0.9 | 0.0 | 0.0 | 0.0 | | 9.0 | 0.09 | 0.03 | 0.87 | 0.0 | 0.01 | 0.0 | | 10.0 | 0.14 | 0.04 | 0.8 | 0.0 | 0.01 | 0.0 | | 11.0 | 0.13 | 0.01 | 0.85 | 0.0 | 0.0 | 0.0 | | 12.0 | 0.24 | 0.08 | 0.65 | 0.01 | 0.0 | 0.01 | | 13.0 | 0.29 | 0.11 | 0.55 | 0.0 | 0.03 | 0.02 | | 14.0 | 0.27 | 0.1 | 0.55 | 0.02 | 0.04 | 0.03|
238
null
|Characteristic | YLL | YLD | |---|---|---| | Lung | 151578.95 | 14035.09 | | Colon and rectum | 78596.49 | 20713.85 | | Breast | 56869.57 | 20498.86 | | Stomach | 44695.65 | 5391.3 | | Prostate | 23185.84 | 10442.48 | | Bladder | 22477.88 | 10265.49 | | Leukaemias | 28495.58 | 3539.82 | | Liver | 30619.47 | 1415.93 | | Pancreas | 30619.47 | 707.96 | | Brain | 26017.7 | 1769.91 | | Non-Hodgkin's | 21415.93 | 5132.74 | | Uterus and cervix | 16551.72 | 6811.11 | | Oesophagus | 16896.55 | 1551.72 | | Ovary | 15517.24 | 2413.79 | | Kidney | 13448.28 | 1724.14 | | Multiple myeloma | 10344.83 | 1034.48 | | Melanoma | 7586.21 | 2068.97 | | Gall Bladder | 9310.34 | 344.83 | | Hodgkin's | 4137.93 | 2068.97 | | Thyroid | 2068.97 | 1551.72|
239
null
|Characteristic | Value | |---|---| | Ht | 8.16 | | Lv | 6.84 | | Sp | 10.48 | | Lu | 8.89 | | Kd | 18.9 | | Ms | 1.07 | | Fa | 6.17 | | Ly | 8.16 | | Br | 5.51 | | Si | 10.15 | | Li | 3.85|
240
null
|Characteristic | MSUP_PA | PSUP_PA | MSUP_FV | PSUP_FV | |---|---|---|---|---| | Cluster 1 | 1.22 | 1.2 | 0.87 | 0.76 | | Cluster 2 | -0.93 | -0.89 | -1.2 | -0.81 | | Cluster 3 | 0.21 | 0.39 | -0.67 | -0.11 | | Cluster 4 | -0.55 | -0.41 | 0.46 | 0.88 | | Cluster 5 | 0.2 | -0.75 | 0.51 | -1.07|
241
null
|Characteristic | non fatal | fatal | |---|---|---| | <20 | 10.03 | -0.09 | | >20-22 | -0.09 | -0.02 | | >22-24 | -0.09 | 9.62 | | >24-26 | 20.06 | 4.65 | | >26-28 | 20.06 | 9.5 | | >28-30 | 20.06 | 38.21 | | >30-32 | 10.03 | 23.86 | | >32-34 | 10.03 | 14.25 | | >34-36 | -0.02 | -0.02 | | >36-38 | 10.03 | -0.02|
242
null
|Characteristic | (G) | (P) | |---|---|---| | G1 | 0.0 | 0.03 | | G2 | 0.17 | 0.93 | | G3 | 0.59 | 0.5 | | G4 | 0.99 | 1.08 | | G5 | 1.31 | 1.4 | | G6 | 1.54 | 1.19 | | G7 | 1.95 | 1.9 | | G8 | 2.4 | 2.58 | | G9 | 2.64 | 2.55 | | G10 | 2.88 | 2.46 | | G11 | 4.0 | 4.34 | | G12 | 4.12 | 3.77|
243
null
|Characteristic | CON | ALC | |---|---|---| | RPTP? | 1.66 | 1.24 | | Contactin | 1.4 | 1.55 | | Caspr1 | 1.31 | 1.35|
244
null
|Characteristic | Value | |---|---| | Monosomy | 0.36 | | Trisomy | 0.21 | | Dual | 0.29 | | Complex | 0.15|
245
null
|Characteristic | Value | |---|---| | 1010.75 | 0.87 | | 1501.79 | 0.87 | | 2010.75 | 0.85 | | 2505.38 | 0.83 | | 3000.0 | 0.84 | | 3508.96 | 0.84 | | 4512.54 | 0.84 | | 5014.34 | 0.85 | | 5516.13 | 0.85 | | 6010.75 | 0.86|
246
null
|Characteristic | Value | |---|---| | Group I | 0.03 | | Group II | 0.01 | | GroupIII | 0.01 | | Group IV | 0.02 | | Group V | 0.02 | | Group VI | 0.02|
247
null
|Characteristic | Value | |---|---| | 0.0 | 1.98 | | 0.89 | 1.8 | | 3.3 | 1.65 | | 4.99 | 1.46 | | 8.29 | 1.28 | | 12.38 | 1.15 | | 20.67 | 1.02 | | 33.76 | 0.95 | | 49.09 | 0.95|
248
null
|Characteristic | Foetal calf serum | 1 ug/mL AFP in PBS | |---|---|---| | unblocked | 25.85 | 111.28 | | 1 wt% BSA-blocked | 3.17 | 22.96 | | 10 mM EA-capped | -3.83 | 93.42|
249
null
|Characteristic | Value | |---|---| | 0.0 | 325.68 | | 1.0 | 491.4 | | 2.0 | 364.34 | | 3.0 | 491.4 | | 4.0 | 473.36 | | 5.0 | 519.75|
250
null
|Characteristic | Value | |---|---| | Glucagon + Hemin | 1.02 | | Insulin + Hemin | 0.64 | | Hemin | 1.0|
251
null
|Characteristic | CFM without slag | SFM with 50% slag | |---|---|---| | Air | 0.65 | 0.62 | | 7TWater+21 Air | 0.72 | 0.63 | | Natural weather | 0.69 | 0.68 | | 7Water+21 Natural | 0.7 | 0.68|
252
null
|Characteristic | True for me | Sometimes true for me | Not true for me | |---|---|---|---| | I did something else on the same day | 41.33 | 23.01 | 35.36 | | I prefer to play with my friends | 28.54 | 24.28 | 47.8 | | The activities were too easy. | 23.01 | 29.4 | 48.23 | | When I signed up I thought it would be different | 28.12 | 40.05 | 32.29 | | I was too busy | 28.54 | 19.17 | 52.74 | | I did not like some of the other pupils in Action 3:30 | 27.27 | 28.97 | 44.22 | | I could not be picked up from school after the club | 15.76 | 8.95 | 75.75 | | I prefer to watch TV or play on my computer | 11.93 | 19.17 | 69.36 | | I did not want to go | 12.36 | 18.32 | 69.78 | | I did not like Action 3:30 | 8.95 | 20.02 | 71.49 | | I did not like the Action 3:30 Leaders | 2.56 | 6.39 | 91.51 | | The activities were too hard | 4.26 | 19.6 | 76.43 | | My parents did not want me to attend | 2.56 | 2.98 | 94.75|
253
null
|Characteristic | Value | |---|---| | Home | 6.03 | | Waterpipe| |café | 58.02 | | Other café | 27.94 | | Restaurant | 1.52 | | Tea house/| |garden | 5.8 | | Other | 1.68|
254
null
|Characteristic | Men | Women | |---|---|---| | 18-24 | 7.13 | 7.08 | | 25-34 | 10.3 | 5.23 | | 35-44 | 6.96 | 7.99 | | \geq45 | 8.03 | 3.71|
255
null
|Characteristic | Value | |---|---| | 9 yrs | -3.05 | | 14 yrs | 0.91 | | 1/30,000 | -13.05 | | 1/750,000 | 6.98 | | 25 yrs | 9.05 | | Lifetime | 11.99 | | 50% | -10.02 | | 90% | 4.04|
256
null
|Characteristic | Male | femal | Total | |---|---|---|---| | cardiac lesions | 0.05 | 0.03 | 0.04 | | coronary dilation | 0.04 | 0.02 | 0.03 | | coronary aneurysm | 0.0 | 0.0 | 0.0 | | giant coronary aneurysm | 0.0 | 0.0 | 0.0 | | coronary narrowing | 0.0 | 0.0 | 0.0 | | valvular lesions | 0.01 | 0.01 | 0.01|
257
null
|Characteristic | no | mostly no | mostly yes | yes | |---|---|---|---|---| | Globally| |satisfied | 0.0 | 0.0 | 0.06 | 0.94 | | Intervention| |length was| |acceptable | 0.0 | 0.03 | 0.09 | 0.88 | | Physical| |annoyances| |were| |acceptable | 0.09 | 0.06 | 0.23 | 0.62 | | Recommend| |toa friend | 0.0 | 0.03 | 0.09 | 0.88|
258
null
|Characteristic | Men | Women | |---|---|---| | 1994.0 | 70.0 | 65.0 | | 1996.0 | 56.0 | 50.0 | | 1998.0 | 38.0 | 40.0 | | 2000.0 | 37.0 | 38.0 | | 2002.0 | 47.0 | 49.0 | | 2004.0 | 50.0 | 53.0 | | 2006.0 | 55.0 | 58.0 | | 2008.0 | 59.0 | 65.0 | | 2010.0 | 59.0 | 59.0|
259
null
|Characteristic | Having after-school PA | Not having after-school PA | |---|---|---| | September | 18358.42 | 14229.39 | | October | 17799.28 | 14057.35 | | November | 18315.41 | 13713.26 | | December | 16853.05 | 14086.02 | | January | 17240.14 | 13440.86 | | February | 17799.28 | 12594.98 | | March | 18573.48 | 13440.86 | | April | 17842.29 | 15390.68 | | May | 18186.38 | 15949.82 | | June | 19476.7 | 16336.92|
260
null
|Characteristic | Value | |---|---| | c.p. Ti | 2.84 | | Ti-5Sn | 6.08 | | Ti-5Sn-1Mo | 13.65 | | Ti-5Sn-3Mo | 21.47 | | Ti-5Sn-5Mo | 25.84 | | Ti-5Sn-7.5Mo | 27.44 | | Ti-5Sn-10Mo | 37.02 | | Ti-5Sn-12.5Mo | 26.68 | | Ti-5Sn-15Mo | 20.93 | | Ti-5Sn-17.5Mo | 18.12 | | Ti-5Sn-20Mo | 17.43|
261
null
|Characteristic | Value | |---|---| | Symptoms | 55.84 | | High risk groups | 44.89 | | Cause | 37.87 | | Treatment | 34.99 | | Mode of transmission | 34.9 | | Prevention | 23.95 | | Diagnosis | 12.96 | | Latent infection | 11.95|
262
null
|Characteristic | Control | Intervention | |---|---|---| | 1.0 | 26.13 | 23.06 | | 2.0 | 30.76 | 21.94 | | 3.0 | 31.33 | 24.23 | | 4.0 | 35.88 | 28.2|
263
null
|Characteristic | SCHSCO | SCHSC10 | SCHSC20 | SCHSC30 | SCHSC50 | |---|---|---|---|---|---| | 0.0 | 1.16 | 0.55 | 2.03 | 3.77 | 2.09 | | 28.0 | 269.01 | 221.67 | 214.95 | 206.08 | 230.27 | | 56.0 | 310.69 | 245.16 | 229.47 | 229.87 | 254.47 | | 90.0 | 330.16 | 274.49 | 270.07 | 265.61 | 295.3 | | 120.0 | 371.1 | 319.46 | 310.61 | 303.98 | 330.63 | | 180.0 | 387.34 | 324.07 | 313.7 | 305.62 | 358.82|
264
null
|Characteristic | Value | |---|---| | 0.0 | 100.27 | | 0.02 | 121.98 | | 0.2 | 95.65 | | 0.4 | 37.9|
265
null
|Characteristic | Value | |---|---| | 1950.0 | 0.15 | | 1959.98 | 5.91 | | 1969.95 | 17.67 | | 1980.21 | 18.79 | | 1990.46 | 72.57 | | 2000.43 | 92.45 | | 2010.68 | 74.37|
266
null
|Characteristic | Value | |---|---| | NS | 69.14 | | PNS | 299.23 | | NS | 71.3 | | PNS | 312.73 | | NS | 70.76 | | PNS | 282.48 | | NS | 65.9 | | PNS | 257.64|
267
null
|Characteristic | others | Sweden | Germany | Japan | Australia | USA | Canada | England | |---|---|---|---|---|---|---|---|---| | 2001-2003 | 80.22 | 18.05 | 18.05 | 46.13 | 66.18 | 58.16 | 152.41 | 164.45 | | 2004-2006 | 80.22 | 14.04 | 12.03 | 24.07 | 68.19 | 26.07 | 62.17 | 98.27 | | 2007-2009 | 64.17 | 24.07 | 20.05 | 12.03 | 48.13 | 8.02 | 4.01 | 20.05|
268
null
|Characteristic | Value | |---|---| | 0.0 | 40.0 | | 1.0 | 49.7 | | 2.0 | 64.0 | | 3.0 | 75.0|
269
null
|Characteristic | Microsimulation | Agent based | Network | State transition | Optimization | Risk assesment | Projection | Game | Behavioral/stress | Diffusion | |---|---|---|---|---|---|---|---|---|---|---| | Place of residence | 5.03 | 1.01 | 0.04 | 1.9 | 13.05 | 4.03 | 0.97 | 0.04 | 0.0 | 1.01 | | Race/ ethinicity | 2.05 | -0.02 | 0.97 | 13.05 | -0.02 | 2.95 | 0.04 | 0.0 | 0.0 | -0.04 | | Economic status | 6.06 | 3.91 | 0.04 | 6.06 | -0.06 | 1.0 | 1.06 | 0.96 | -0.03 | 0.0 | | Education | 3.02 | 0.07 | 0.0 | 2.91 | 1.03 | 0.95 | 0.04 | 0.04 | -0.07 | 1.04 | | Gender | 1.04 | 0.02 | -0.02 | 5.0 | 0.03 | -0.03 | 0.99 | -0.03 | 1.03 | 0.0 | | Occipation | 4.04 | 0.0 | 0.0 | 0.93 | 1.08 | -0.02 | 0.03 | 0.0 | 0.93 | 0.03 | | Insurance coverage | 3.02 | 0.06 | -0.02 | 1.98 | -0.04 | 0.04 | -0.04 | 0.0 | 0.04 | -0.07 | | Martial status | 3.06 | 0.02 | 0.0 | 0.93 | 0.99 | 0.04 | -0.04 | -0.04 | 0.07 | 0.0 | | Social Capital | 0.0 | 0.02 | 1.04 | 1.94 | -0.02 | 1.04 | 0.0 | 0.0 | 0.0 | 0.04 | | Sociocultultural factors | -0.04 | 0.05 | -0.02 | 0.02 | 0.0 | 0.0 | 1.04 | 0.94 | 0.04 | -0.02 | | Housing | 0.0 | 0.02 | 0.0 | 1.03 | 0.0 | 0.0 | -0.07 | 0.04 | 0.04 | -0.04|
270
null
|Characteristic | Type I | Type II | |---|---|---| | L121 | 62.92 | 37.86 | | P123 | 65.12 | 35.44 | | F127 | 81.61 | 18.73|
271
null
|Characteristic | Value | |---|---| | A | 6.11 | | B | 1.2 | | C | 9.3 | | D | 4.06 | | AC | 11.55 | | AD | 6.64 | | BD | 1.06 | | A^2 | 12.64 | | B^2 | 10.45 | | C^2 | 13.55 | | D^2 | 22.91|
272
null
|Characteristic | 1 wt % | 2 wt % | 3 wt % | 4 wt % | 5 wt % | |---|---|---|---|---|---| | 15.0 | 6.04 | 5.0 | 7.03 | 7.55 | 8.02 | | 20.0 | 7.03 | 8.02 | 8.49 | 8.02 | 10.05 | | 25.0 | 7.03 | 9.01 | 12.03 | 13.02 | 13.02 | | 30.0 | 8.54 | 12.03 | 13.02 | 15.0 | 16.53 | | 35.0 | 15.0 | 13.99 | 15.0 | 16.04 | 16.98|
273
null
|Characteristic | first grade | second grade | |---|---|---| | MVPA | 128.46 | 142.6 | | Moderate PA | 121.87 | 135.06 | | Vigorous PA | 7.35 | 8.77|
274
null
|Characteristic | Torsion | Tension | |---|---|---| | Q235 | 81.1 | 451.0 | | AL6061 | 226.8 | 4.4 | | SS316 | 11.3 | 137.6 | | LYS160 | 1923.1 | 65.4|
275
null
|Characteristic | IL-10 (S1) | AgPVP-IL10 | |---|---|---| | Cells | 1.49 | 1.49 | | LPS | 242.05 | 0.5 | | 0.01 | 240.06 | 217.2 | | 0.1 | 171.47 | 231.11 | | 1.0 | 113.82 | 167.5 | | 10.0 | 24.35 | 1.49|
276
null
|Characteristic | Baseline (Former Smoker) | Follow-up(Former smoker) | Baseline(Current smoker) | Follow-up (Current smoker) | |---|---|---|---|---| | 19-39 | 34.63 | 20.5 | 35.86 | 27.28 | | 40-59 | 22.76 | 10.42 | 26.25 | 18.71 | | 60- | 19.94 | 6.37 | 10.23 | 7.31|
277
null
|Characteristic | Adaption Actions | Groundwork Initiatives | |---|---|---| | United States | 0.39 | 0.61 | | Switzerland | 0.14 | 0.86 | | Canada | 0.18 | 0.82 | | France | 0.67 | 0.33 | | United Kingdom | 0.39 | 0.61 | | Belgium | 0.53 | 0.47 | | Australia | 0.38 | 0.62 | | Luxemborg | 0.86 | 0.14 | | New Zealand | 0.5 | 0.5 | | Ireland | 0.33 | 0.67 | | Average | 0.38 | 0.62|
278
null
|Characteristic | Value | |---|---| | A1 | 9.82 | | A2 | 13.74 | | A3 | 12.45 | | A4 | 15.14 | | A5 | 13.25|
279
null
|Characteristic | Women | Men | |---|---|---| | Elevated triglycerides | 38.03 | 50.13 | | Hypertension | 44.94 | 33.09 | | Elevated plasma glucose | 43.95 | 39.26 | | Low HDL | 95.56 | 94.58 | | Centripetal obesity | 81.74 | 34.08|
280
null
|Characteristic | By InterVA | By Physican | |---|---|---| | Undetermined | 6.89 | 14.98 | | Accident/injuries | 10.12 | 12.86 | | Tuberculosis | 13.8 | 12.64 | | CVD | 8.08 | 11.49 | | Neoplasms | 11.7 | 5.33 | | ALRTI | 10.57 | 5.29 | | Pnemonia/sepsis | 4.85 | 4.8 | | Acute Infections | 4.85 | 4.36 | | Meningitis | 1.16 | 4.17 | | Perinatal | 3.71 | 3.93 | | GI | 5.75 | 3.51 | | Renal disorder | 1.16 | 3.02 | | Malaria | 2.75 | 3.0 | | Mental | 3.03 | 2.78 | | HIV/AIDS | 3.03 | 2.55 | | ONCD | 2.75 | 1.87 | | COPD | 3.26 | 1.64 | | Malnutrition | 2.3 | 1.4 | | Maternal | 0.23 | 0.45|
281
null
|Characteristic | Value | |---|---| | CH | 2.28 | | CH-PEO | 1.93 | | CH-PEO/HA | 1.26|
282
null
|Characteristic | plausible | don't know | implausible | |---|---|---|---| | tinnitus/ ringing in the ears (10,4%) | 0.8 | 0.1 | 0.1 | | difficulties concentrating(20,6%) | 0.7 | 0.05 | 0.25 | | tumours (5,2%) | 0.6 | 0.2 | 0.2 | | sleep disorders (102,43%) | 0.57 | 0.18 | 0.25 | | headache (93,39%) | 0.55 | 0.15 | 0.3 | | nervousness/ restlessness (28, 12%) | 0.53 | 0.25 | 0.21 | | cardiac arrythmia (4, 2%) | 0.5 | 0.0 | 0.5 | | tiredness / fatigue (32,14%) | 0.5 | 0.12 | 0.37 | | anxiety(8,3%) | 0.37 | 0.12 | 0.5 | | vertigo(24,10%) | 0.33 | 0.25 | 0.41|
283
null
|Characteristic | Value | |---|---| | CH-PEO/HA/Pac | 4.99 | | CH-PEO/HA+Pac | 18.27 | | CH-PEO/HA | 66.53 | | Control | 99.88|
284
null
|Characteristic | BM42 | RM | BM19 | B10 | BM34 | BM26 | BM36 | BM35 | BM50 | |---|---|---|---|---|---|---|---|---|---| | 20°C | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 200°C | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | | 600°C | 0.04 | 0.08 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.05 | 0.07 | | 800°C | 0.1 | 0.21 | 0.12 | 0.11 | 0.1 | 0.11 | 0.17 | 0.09 | 0.18 | | 1000°C | 0.25 | 0.41 | 0.23 | 0.29 | 0.22 | 0.29 | 0.35 | 0.24 | 0.37|
285
null
|Characteristic | Boys | Girls | |---|---|---| | Art Grass | 31.31 | 42.22 | | Forest | 64.02 | 52.77 | | Hill | 34.83 | 0.26 | | City | 40.11 | 34.23 | | Art Grass | 31.31 | 42.22 | | Forest | 64.02 | 52.77 | | Hill | 34.83 | 0.26 | | City | 40.11 | 34.23 | | Art Grass | 31.31 | 42.22 | | Forest | 64.02 | 52.77 | | Hill | 34.83 | 0.26 | | City | 40.11 | 34.23|
286
null
|Characteristic | Yes | No | |---|---|---| | <1 year | 33.3 | 33.3 | | 1-4 years | 14.3 | 85.7 | | 5-10 years | 0.0 | 100.0 | | > 10 years | 0.0 | 100.0|
287
null
|Characteristic | Me1 | Me2 | realized | |---|---|---|---| | W6W_within | 0.9 | 0.58 | 0.51 | | WGS_within | 0.82 | 0.44 | 0.48 | | Bt_within | 0.67 | 0.31 | 0.46 | | %CDB+_within | 0.87 | 0.53 | 0.64 | | CDS+/CD4+_within | 0.86 | 0.51 | 0.66 | | W6W_across | 0.9 | 0.59 | 0.17 | | WGS_across | 0.82 | 0.45 | 0.28 | | BL_across | 0.67 | 0.3 | 0.26 | | %CDB+_across | 0.87 | 0.53 | 0.43 | | CDS+/CD4+_across | 0.86 | 0.51 | 0.44|
288
null
|Characteristic | GMAC-40 | PAC | |---|---|---| | unageing | 2.22 | 1.62 | | STA | 2.23 | 1.64 | | LTA | 2.26 | 1.66 | | UV-2month | 2.23 | 1.63 | | UV-4month | 2.24 | 1.64 | | UV-6month | 2.25 | 1.65|
289
null
|Characteristic | Value | |---|---| | 0,05 | 64.94 | | 0,1 | 29.94 | | 0,15 | 11.07 | | 0,2 | 4.6 | | 0,25 | 8.89 | | 0,3 | 4.79 | | 0,35 | 4.79 | | 0,4 | 0.14 | | 0,45 | 4.24 | | 0,5 | 0.14|
290
null
|Characteristic | Baseline | Follow-up | |---|---|---| | 19-29 | 32.88 | 29.31 | | 30-39 | 35.2 | 16.9 | | 40-49 | 24.22 | 12.88 | | 50-59 | 21.36 | 8.06 | | 60- | 19.93 | 6.36|
291
null
|Characteristic | Value | |---|---| | Repair with| |composite | 0.25 | | Replace the| |restoration | 0.61 | | Ceramic| |inlay | 0.04 | | Inlay| |(CAD/CAM) | 0.02 | | Gold inlay | 0.03 | | Crown | 0.04|
292
null
|Characteristic | English | LOTE | |---|---|---| | Terrorism likely | 16.29 | 13.63 | | Concerned self or family would be directly affected | 17.33 | 30.99 | | Changed way of living due to possibility of terrorism | 11.8 | 23.12|
293
null
|Characteristic | normal weight | overweight/obese | |---|---|---| | MVPA | 132.97 | 182.33 | | Moderate PA | 125.57 | 171.22 | | Vigorous PA | 7.13 | 13.29|
294
null
|Characteristic | Value | |---|---| | Lack of patient interest | 0.81 | | Lack of staff | 0.69 | | Lack of refferal resource | 0.69 | | Lack of training | 0.71 | | More pressing issues | 0.63 | | Lack of reminder system | 0.54 | | Time constrain | 0.28|
295
null
|Characteristic | Value | |---|---| | -0.0 | -0.0 | | -0.0 | 0.7 | | 0.0 | 0.76 | | 0.02 | 0.81 | | 0.02 | 0.86 | | 0.03 | 0.89 | | 0.05 | 0.9 | | 0.08 | 0.9 | | 0.09 | 0.92 | | 0.11 | 0.92 | | 0.11 | 0.96 | | 0.31 | 0.96 | | 0.31 | 0.98 | | 0.69 | 0.98 | | 0.69 | 1.0 | | 1.0 | 1.0|
296
null
|Characteristic | 1 wt% | 2wt% | 3 wt% | 4 wt % | 5 wt % | |---|---|---|---|---|---| | 15.0 | 88.32 | 86.32 | 84.32 | 85.52 | 82.33 | | 20.0 | 86.42 | 85.52 | 85.52 | 84.72 | 83.54 | | 25.0 | 85.14 | 83.38 | 83.52 | 82.72 | 81.47 | | 30.0 | 85.46 | 84.18 | 84.32 | 83.92 | 83.52 | | 35.0 | 84.66 | 83.52 | 82.11 | 80.33 | 79.13|
297
null
|Characteristic | At least one problem | Problem-free | |---|---|---| | 14-19 | 12.66 | 139.2 | | 20-29 | 39.03 | 234.1 | | 30-39 | 57.48 | 248.6 | | 40-49 | 97.02 | 299.12 | | 50-59 | 145.13 | 184.01 | | 60-69 | 153.7 | 136.56 | | 70-79 | 180.06 | 70.0 | | 80+ | 50.23 | 4.76|
298
null
|Characteristic | [unnamed data series #0] | [unnamed data series #1] | |---|---|---| | Time 1 | 2.23 | 2.26 | | Time 2 | 3.03 | 2.59 | | Time 3 | 3.16 | 3.08|
299